Emerging Fungus, Candida auris: A Case Report

Abstract

Candida auris is a growing fungal threat that has sparked global concern. It has been linked to healthcare-related outbreaks and infections around the world and has been reported in numerous countries. This case report describes an infection caused by Candida auris in a 21-year-old patient with a prolonged hospital stay. On the 60^th day of admission, the patient developed persistent fever and cerebrospinal fluid culture revealed Candida spp. Identification of the species and antimicrobial susceptibility testing was done by VITEK-2. The isolate was sensitive to flucytosine and voriconazole and resistant to fluconazole and amphotericin B. Voriconazole was started after the culture and sensitivity results.